Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 2/20 | 0.55 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.55 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.55 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.38 |
| ▸ | GSK3B | P49841 | 4/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.38 |
| ▸ | WNT1 | P04628 | 3/20 | 0.38 |
| ▸ | ACVR1 | Q04771 | 5/20 | 0.38 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.37 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.37 |
| ▸ | BMPR1A | P36894 | 1/20 | 0.37 |
| ▸ | ACVR1B | P36896 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TYRO3 | Q06418 | 4/20 | 0.34 |
| ▸ | AXL | P30530 | 2/20 | 0.34 |
| ▸ | MERTK | Q12866 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2280097 | 1.00 | MAPK8 (0.55) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL7945004 | 1.00 | MAPK8 (0.55) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL2753230 | 0.85 | MAPK8 (0.60) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL4401919 | 0.85 | MAPK8 (0.60) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL2753233 | 0.85 | MAPK8 (0.60) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL2278431 | 0.84 | WNT1 (0.38) | MAPK8GSK3BDYRK1AWNT1TYRO3 | |
| SCHEMBL2282633 | 0.84 | MAPK8 (0.37) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL2752875 | 0.84 | MAPK8 (0.57) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL4402816 | 0.84 | MAPK8 (0.57) | MAPK8MAPK9MAPK10IRAK4GSK3B | |
| SCHEMBL2752873 | 0.84 | MAPK8 (0.57) | MAPK8MAPK9MAPK10IRAK4GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110195951-A1 | DIAZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2011-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110195951-A1 | DIAZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE | DAPK1, DAPK2, DAPK3 | MAPK8 53/4885MAPK9 27/4885MAPK10 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.